Genomics of epidemic pathogens

Slides:



Advertisements
Similar presentations
Genomic analysis of three African strains of Bacillus anthracis demonstrates that they are part of the clonal expansion of an exclusively pathogenic bacterium.
Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Lipooligosaccharide locus class of Campylobacter jejuni: sialylation is not needed for invasive infection  P. Ellström, B. Feodoroff, M.-L. Hänninen,
C.N. van Ettekoven, D. van de Beek, M.C. Brouwer 
Gut bacterial microbiota and obesity
L.H. Su, T.L. Wu, C.H. Chiu  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
The importance of enterovirus surveillance in a Post-polio world
Clinical Microbiology and Infection
Tracking changes in the vraSR and graSR two component regulatory systems during the development and loss of vancomycin non-susceptibility in a clinical.
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
A. Fajardo, J.F. Linares, J.L. Martínez 
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
Clinical Microbiology and Infection
The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health  R.M. Davies  Clinical Microbiology and Infection 
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
The occurrence of Legionella species other than Legionella pneumophila in clinical and environmental samples in Denmark identified by mip gene sequencing.
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Plague in the genomic area
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Community-acquired acute bacterial meningitis in the elderly in Turkey
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Genomics of epidemic pathogens K. Georgiades  Clinical Microbiology and Infection  Volume 18, Issue 3, Pages 213-217 (March 2012) DOI: 10.1111/j.1469-0691.2012.03781.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Creation of an epidemic pathogen. Non-specialized bacterial species constitute ‘pre-species’ that have a community lifestyle and are able to exchange genes. After specialization, the number of horizontal gene transfers (HGTs) is reduced, until total genetic isolation has been acheived. Only gene loss is then possible, the bacterium is deregulated, and virulence capacity is initiated. The arrows show HGT and gene loss. TA, toxin–antitoxin. Clinical Microbiology and Infection 2012 18, 213-217DOI: (10.1111/j.1469-0691.2012.03781.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions